Nobel prize for medicine goes to Katalin Karikó and Drew Weissman for their mRNA work behind the covid-19 vaccines

Spread the love

Katalin Karikó and Drew Weissman have been awarded the Nobel prize in medicine

Katalin Karikó and Drew Weissman have been awarded the Nobel prize in physiology or drugs

Niklas Elmehed/Nobel Prize Outreach

Two scientists whose work led to the mRNA vaccines in opposition to covid-19 have been awarded the 2023 Nobel prize in physiology or drugs.

Katalin Karikó and Drew Weissman had been awarded the prize for his or her work on chemically altering strands of mRNA, which made it attainable to make use of them in vaccines.

The know-how was licensed by US biotech agency Moderna in addition to German biotech agency BioNTech – the place Karikó went to work – which then collaborated with the multinational Pfizer. This led to 2 of the principle covid-19 vaccines utilized in high-income nations, from Moderna and Pfizer/BioNTech.

mRNA is a “messenger” molecule that enables genetic info saved in DNA, within the cell nucleus, to be transported to protein-making factories referred to as ribosomes elsewhere within the cell.

There had lengthy been curiosity in utilizing mRNA medically to instruct human cells to fabricate proteins that they might not usually make. But when artificially synthesised mRNA is injected into the physique, it appears just like mRNA produced by micro organism – and so is destroyed by numerous immune chemical compounds.

Whereas on the College of Pennsylvania within the Nineteen Nineties, Karikó and Weissman labored out a technique to chemically tweak synthesised mRNA in order that it appears just like the model naturally made by mammalian cells – and so keep away from the immune assault.

Within the covid-19 vaccine, the mRNA comprises directions for making the coronavirus spike protein, a molecule on the skin of virus particles. When somebody is given the vaccine, their cells begin to make this protein, which triggers a traditional immune response.

The Moderna and Pfizer/BioNTech vaccines had been broadly rolled out in high-income nations from early 2021 onwards. Initially they had been extremely profitable at stopping folks from being contaminated with covid-19.

They’re much less profitable at stopping infections with the omicron variants of the virus, which started spreading in late 2021. Nevertheless, the vaccines are nonetheless efficient at lowering sickness severity and stopping deaths.

Many nations within the northern hemisphere have lately restarted covid-19 booster campaigns earlier than an anticipated winter surge of the virus – though it’s debated whether or not they need to now be supplied to most individuals or solely those that are extra weak.

The mRNA covid-19 vaccines helped stop numerous deaths and extreme unwell well being from the coronavirus and enabled societies to open up once more, stated Thomas Perlmann, the secretary of the Nobel Committee for Physiology or Medication, at an announcement on 2 October. “The work had a significant influence on society throughout the current pandemic.”

One other benefit of mRNA know-how is that it permits vaccines to be made extra rapidly in opposition to any new viruses – reminiscent of a fowl flu pandemic, stated Perlmann. “Future vaccines based mostly on mRNA have the potential to grow to be scalable, quick and versatile.”

They’re additionally being investigated as potential therapies for most cancers.


Spread the love

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top